111 related articles for article (PubMed ID: 11278050)
1. Symmetry-based inhibitors of HIV-1 protease. Design, synthesis and preliminary structure-activity studies of acylated 2,3-diamino-1-hydroxypropanes and 2,4 diamino-1-hydroxybutanes.
Marastoni M; Bazzaro M; Bortolotti F; Salvadori S; Tomatis R
Eur J Med Chem; 1999; 34(7-8):651-7. PubMed ID: 11278050
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 protease inhibitors containing a novel C2 symmetrical hydroxyalkylgem-diamino core structure.
Marastoni M; Salvadori S; Bortolotti F; Tomatis R
J Pept Res; 1997 Jun; 49(6):538-44. PubMed ID: 9266481
[TBL] [Abstract][Full Text] [Related]
3. Aminodiol HIV protease inhibitors. 1. Design, synthesis, and preliminary SAR.
Barrish JC; Gordon E; Alam M; Lin PF; Bisacchi GS; Chen P; Cheng PT; Fritz AW; Greytok JA; Hermsmeier MA
J Med Chem; 1994 Jun; 37(12):1758-68. PubMed ID: 8021916
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and activity of N-benzyl pseudopeptides HIV protease inhibitors.
Marastoni M; Bazzaro M; Bortolotti F; Tomatis R
Bioorg Med Chem; 2003 May; 11(11):2477-83. PubMed ID: 12735995
[TBL] [Abstract][Full Text] [Related]
5. HIV-1 protease inhibitors containing an N-hydroxyamino acid core structure.
Marastoni M; Bazzaro M; Salvadori S; Bortolotti F; Tomatis R
Bioorg Med Chem; 2001 Apr; 9(4):939-45. PubMed ID: 11354677
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo.
Lee T; Laco GS; Torbett BE; Fox HS; Lerner DL; Elder JH; Wong CH
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):939-44. PubMed ID: 9448264
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of HIV-1 protease inhibitors containing gem-diaminoserine core unit.
Marastoni M; Bortolotti F; Salvadori S; Tomatis R
Arzneimittelforschung; 1998 Jun; 48(6):709-12. PubMed ID: 9689433
[TBL] [Abstract][Full Text] [Related]
8. Design and synthesis of HIV-1 protease inhibitors. Novel tetrahydrofuran P2/P2'-groups interacting with Asp29/30 of the HIV-1 protease. Determination of binding from X-ray crystal structure of inhibitor protease complex.
Oscarsson K; Lahmann M; Lindberg J; Kangasmetsä J; Unge T; Oscarson S; Hallberg A; Samuelsson B
Bioorg Med Chem; 2003 Mar; 11(6):1107-15. PubMed ID: 12614898
[TBL] [Abstract][Full Text] [Related]
9. Potent HIV protease inhibitors containing a novel (hydroxyethyl)amide isostere.
Beaulieu PL; Wernic D; Abraham A; Anderson PC; Bogri T; Bousquet Y; Croteau G; Guse I; Lamarre D; Liard F; Paris W; Thibeault D; Pav S; Tong L
J Med Chem; 1997 Jul; 40(14):2164-76. PubMed ID: 9216835
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of novel P2 substituents in diol-based HIV protease inhibitors.
Adrian Meredith J; Wallberg H; Vrang L; Oscarson S; Parkes K; Hallberg A; Samuelsson B
Eur J Med Chem; 2010 Jan; 45(1):160-70. PubMed ID: 19926360
[TBL] [Abstract][Full Text] [Related]
11. Potent HIV-1 protease inhibitors incorporating meso-bicyclic urethanes as P2-ligands: structure-based design, synthesis, biological evaluation and protein-ligand X-ray studies.
Ghosh AK; Gemma S; Takayama J; Baldridge A; Leshchenko-Yashchuk S; Miller HB; Wang YF; Kovalevsky AY; Koh Y; Weber IT; Mitsuya H
Org Biomol Chem; 2008 Oct; 6(20):3703-13. PubMed ID: 18843400
[TBL] [Abstract][Full Text] [Related]
12. Structure-based design and synthesis of substituted 2-butanols as nonpeptidic inhibitors of HIV protease: secondary amide series.
Reich SH; Melnick M; Pino MJ; Fuhry MA; Trippe AJ; Appelt K; Davies JF; Wu BW; Musick L
J Med Chem; 1996 Jul; 39(14):2781-94. PubMed ID: 8709109
[TBL] [Abstract][Full Text] [Related]
13. Potent inhibitors of the HIV-1 protease incorporating cyclic urea P1-P2 scaffold.
Kazmierski WM; Furfine E; Gray-Nunez Y; Spaltenstein A; Wright L
Bioorg Med Chem Lett; 2004 Nov; 14(22):5685-7. PubMed ID: 15482948
[TBL] [Abstract][Full Text] [Related]
14. Structure-based design, synthesis, X-ray studies, and biological evaluation of novel HIV-1 protease inhibitors containing isophthalamide-derived P2-ligands.
Ghosh AK; Takayama J; Kassekert LA; Ella-Menye JR; Yashchuk S; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
Bioorg Med Chem Lett; 2015 Nov; 25(21):4903-4909. PubMed ID: 26096678
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and activity of new acylated diaminohydroxyalkanes as human immunodeficiency virus protease inhibitors.
Marastoni M; Bazzaro M; Bortolotti F; Tomatis R
Arzneimittelforschung; 2000 Jun; 50(6):564-8. PubMed ID: 10918952
[TBL] [Abstract][Full Text] [Related]
16. The synthesis of symmetrical and unsymmetrical P1/P1' cyclic ureas as HIV protease inhibitors.
Patel M; Kaltenbach RF; Nugiel DA; McHugh RJ; Jadhav PK; Bacheler LT; Cordova BC; Klabe RM; Erickson-Viitanen S; Garber S; Reid C; Seitz SP
Bioorg Med Chem Lett; 1998 May; 8(9):1077-82. PubMed ID: 9871711
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiviral activities of novel N-alkoxy-arylsulfonamide-based HIV protease inhibitors.
Sherrill RG; Furfine ES; Hazen RJ; Miller JF; Reynolds DJ; Sammond DM; Spaltenstein A; Wheelan P; Wright LL
Bioorg Med Chem Lett; 2005 Aug; 15(15):3560-4. PubMed ID: 15975788
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, X-ray studies, and biological evaluation of novel macrocyclic HIV-1 protease inhibitors involving the P1'-P2' ligands.
Ghosh AK; Sean Fyvie W; Brindisi M; Steffey M; Agniswamy J; Wang YF; Aoki M; Amano M; Weber IT; Mitsuya H
Bioorg Med Chem Lett; 2017 Nov; 27(21):4925-4931. PubMed ID: 28958624
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of sulfoximine based inhibitors for HIV-1 protease.
Raza A; Sham YY; Vince R
Bioorg Med Chem Lett; 2008 Oct; 18(20):5406-10. PubMed ID: 18829317
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of P1'-functionalized macrocyclic transition-state mimicking HIV-1 protease inhibitors encompassing a tertiary alcohol.
De Rosa M; Unge J; Motwani HV; Rosenquist Å; Vrang L; Wallberg H; Larhed M
J Med Chem; 2014 Aug; 57(15):6444-57. PubMed ID: 25054811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
